Integrated CGT CDMO eXmoor offers the only integrated UK CGT CDMO with consultancy embedded at every stage, enabling end-to-end support from early strategy to GMP manufacturing and commercialization. This positions the company to win clients seeking a single partner for both strategy and manufacturing, creating strong cross-sell opportunities for CMC consulting alongside process development and GMP services.

Modality Reach Capability across viral vectors, autologous and allogeneic cell therapies, and RNA technologies creates a broad addressable market from early development to clinical manufacturing. Pitch bundled services to biotech and pharma clients needing a single platform to reduce vendor risk and shorten timelines.

Client Loyalty Strong repeat business, with seventy percent of clients returning for ongoing collaboration, signals high satisfaction and a foundation for multi-year engagements. This creates sales opportunities to expand existing accounts with additional modalities, process development, analytical development, and scale-up manufacturing support.

Leadership & Partnerships Recent leadership appointments and strategic partnerships signal a growth trajectory. New Chair George Fotiades and Chief Commercial Officer Manuel Balbuena, along with partnerships with Signadori Bio and Siam Bioscience, position eXmoor to pursue larger, strategic CGT programs with global partners.

UK Advantage UK-based operations with a culture of transparency, IP freedom, and client-focused collaboration offer a compelling proposition for international biotech firms seeking a trusted partner across strategy to manufacturing. Highlight these differentiators to attract European and global clients, including potential near-term expansions through existing alliances.